Clinical Trial Update: A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for XY03-EA Tablets in acute ischemic stroke is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• XY03-EA Tablets

Snippet

Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Conditions: Acute Ischemic Stroke | Phase 2 | Status: UNKNOWN